Welcome to our dedicated page for Keurig Dr Pepper SEC filings (Ticker: KDP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Keurig Dr Pepper Inc.'s SEC filings document operating results, governance, material events, and capital-structure matters for its beverage and coffee businesses. Form 8-K reports include quarterly and full-year financial results, outlook updates, material agreements, completed acquisition-related events, and other current-report disclosures tied to the company's refreshment beverage portfolio and Keurig coffee platform.
Proxy filings describe shareholder voting matters, board governance, executive compensation, and annual meeting proposals. The filing record also covers security-structure and capital disclosures, risk and financial reporting topics, and governance changes relevant to a public operating company with owned, licensed, and partner beverage and coffee brands.
Keurig Dr Pepper (KDP) reported an insider equity award. On 10/28/2025, an officer serving as Senior VP & Controller received 14,732 restricted stock units (RSUs) at a stated price of $0.
The RSUs vest in two equal installments: 50% on December 31, 2026 and 50% on December 31, 2027. Each RSU represents the right to receive one share of common stock upon vesting. The filing lists direct ownership of 14,732 derivative securities following the grant.
Keurig Dr Pepper Inc. announced two financing steps tied to its tender offer for JDE Peet’s N.V. The company agreed to sell 3,000,000 shares of Series A Convertible Perpetual Preferred Stock at $1,000 per share for $3.0 billion, with a 4.75% annual cash dividend and senior priority over common stock. The preferred initially converts at $37.25 per share, subject to customary anti-dilution and Spin-Off adjustments, with conversion limited by a cap of the lesser of 271,580,767 shares or 19.99% of common shares then outstanding. KDP may require conversion after year three if the stock trades above 150% of the conversion price for 20 of 30 consecutive days, and may redeem at 110%/105%/100% of stated amounts in years seven, eight and nine, respectively. Net proceeds will fund a portion of the JDE Peet’s acquisition.
KDP also secured a $4 billion minority investment into a new Pod Manufacturing JV holding U.S. and Canadian coffee production assets: JV Investors will contribute $4 billion for a 49% interest; KDP retains 51%. Closing conditions include investment-grade ratings, required approvals, asset contributions, and the closing of the JDE Peet’s acquisition. JV fees include a 1% transaction fee (30% earned at signing) and a 0.10% ticking fee after 120 days. Proceeds are intended to help fund the acquisition.
Keurig Dr Pepper (KDP) reported stronger Q3 performance. Net sales were $4,306 million versus $3,891 million a year ago, and net income was $662 million with diluted EPS of $0.49. For the first nine months, net sales reached $12,104 million and net income was $1,726 million. Segment Q3 net sales: U.S. Refreshment Beverages $2,735 million, U.S. Coffee $991 million, and International $580 million.
Strategic and financing updates: KDP agreed to a tender offer for JDE Peet’s at €31.85 per share, expected in the first half of 2026, subject to regulatory approvals and shareholder acceptance. To support the plan, KDP secured an undrawn €16.2 billion 364‑day bridge facility and increased its revolving credit capacity to $4.3 billion. In May, it issued $2 billion of new notes and repaid 2025 Merger Notes at maturity. Operating cash flow for the first nine months was $1,279 million; cash and cash equivalents were $516 million at quarter end.
Keurig Dr Pepper Inc. furnished an Item 7.01 Regulation FD disclosure tied to its investor day. The company provided a press release as Exhibit 99.1 and will post its investor day presentation on its investor relations site at https://investors.keurigdrpepper.com/events-and-presentations.
The press release is titled “KDP Discusses Strategy, Leadership and Financing for Upcoming Transformational Transactions.” Information furnished under Item 7.01 is not deemed “filed” under Section 18 of the Exchange Act unless specifically stated.
Keurig Dr Pepper Inc. (KDP) furnished an update on operations by announcing its Q3 2025 results via a press release. The company said it raised its full‑year net sales outlook and reaffirmed EPS guidance for 2025, according to Exhibit 99.1.
The information under Item 2.02 is furnished, not filed, under the Exchange Act. The press release titled “Keurig Dr Pepper Reports Q3 2025 Results and Raises Full Year Net Sales Outlook and Reaffirms EPS Guidance for 2025” is available as Exhibit 99.1 and on the company’s website.
Keurig Dr Pepper Inc. (KDP) director Whiting Lawson E reported receipt of 3,210 restricted stock units (RSUs) on 09/17/2025. Each RSU represents a contingent right to one share of the issuer's common stock upon vesting. The RSUs were granted at a $0 price and, following the transaction, the reporting person beneficially owns 3,210 shares/units directly. These RSUs are subject to vesting conditions and, subject to certain exceptions, vest on September 17, 2030.
Michael G. Van de Ven, a director of Keurig Dr Pepper Inc. (KDP), was granted 3,210 restricted stock units on 09/17/2025. The Form 4 reports these RSUs as acquired with a reported price of $0 and 3,210 shares beneficially owned following the transaction, held directly. The filing notes the RSUs are subject to vesting and, subject to conditions and exceptions, vest on September 17, 2030, with each RSU converting to one share of common stock upon vesting. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 09/19/2025.
Olivier Lemire, President, U.S. Coffee at Keurig Dr Pepper (KDP), was granted 3,784 restricted stock units (RSUs) on September 17, 2025. Each RSU represents a contingent right to one share of KDP common stock upon vesting. The RSUs are subject to time-based vesting in four equal installments: 25% on September 17 of 2026, 2027, 2028 and 2029. Following the grant, Lemire beneficially owns 3,784 shares represented by these RSUs on a direct basis. The Form 4 was signed by Mark Jackson as attorney-in-fact on September 19, 2025, and indicates the reporting person is both an officer and a director of the issuer.
Keurig Dr Pepper insider Anthony Shoemaker reported stock transactions tied to vesting of restricted stock units (RSUs). On 09/15/2025 Mr. Shoemaker had RSUs convert into common stock and recorded net acquisitions of common shares: 785 shares from a 2021 grant and 1,475 shares from a 2020 grant, resulting in an increase in his beneficial ownership to 125,432 shares following the largest conversion. To cover tax obligations, the issuer withheld 309 and 581 shares at $26.75 per share, recorded as dispositions, leaving reported direct ownership figures shown in the filing. The transactions reflect routine vesting and tax withholding under the company's Omnibus Stock Incentive Plan.
Keurig Dr Pepper Inc. (KDP) insider Roger F. Johnson had matching restricted stock units (RSUs) vest on 09/15/2025, resulting in an issuance of common shares and a tax-withholding disposition. One-third of Matching RSUs granted September 15, 2020 vested on September 15, 2025 and converted one-for-one into common stock under the Issuer's Omnibus Stock Incentive Plan of 2019. A total of 8,680 shares were issued upon conversion and 3,711 shares were withheld to cover taxes at a reported price of $26.75, leaving the reporting person with 115,953 shares beneficially owned after the transactions.